Method for analyzing double-stranded oligonucleotide
By adjusting the delay time and voltages in a MALDI ion trap mass spectrometer, double-stranded oligonucleotides can be effectively analyzed, addressing the detection challenges faced in previous methods and achieving high sensitivity and resolution in MALDI-ITMS analysis.
Patent Information
- Application Number
- PCT/JP2024/017300
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-05-09
- Publication Date
- 2024-11-21
AI Technical Summary
Current mass spectrometry methods, such as MALDI-ITMS, face challenges in analyzing double-stranded oligonucleotides due to their instability in the gas phase and separation issues caused by matrices and solvents, making it difficult to detect molecules like siRNA.
A method involving a MALDI ion trap mass spectrometer with specific settings, including adjusting the delay time based on the molecular weight of the double-stranded oligonucleotide and optimizing voltages for the conversion dynode and secondary electron multiplier, allows for the detection of double-stranded oligonucleotides by trapping and ejecting ions effectively.
This approach enables the sensitive detection of double-stranded oligonucleotides with improved signal intensity and peak resolution, overcoming previous limitations in MALDI-ITMS analysis.
Smart Images

Figure JP2024017300_21112024_PF_FP_ABST
Abstract
Description
Method for analyzing double-stranded oligonucleotides
[0001] The present invention relates to a method for analyzing double-stranded oligonucleotides.
[0002] Nucleic acid drugs, which have nucleic acids such as DNA and RNA as their basic structure, are highly specific because they act by binding to specific base sequences in genes, and are expected to be applied to the treatment of cancer and hereditary diseases that have been difficult to treat until now. There are various types of nucleic acid drugs, but in recent years, many nucleic acid drugs made from siRNA (small interfering RNA), a double-stranded RNA consisting of about 20 base pairs, have been developed.
[0003] The double-stranded structure of nucleic acids is stabilized in the liquid phase by hydrogen bonds formed between base pairs and stacking interactions due to base overlap. However, maintaining this double-stranded structure in the gas phase is difficult. On the other hand, in mass spectrometry using electrospray ionization (ESI) or matrix-assisted laser desorption / ionization (MALDI), sample molecules are ionized in the gas phase. Furthermore, in MALDI-based mass spectrometry, the double strands are easily separated due to the matrix, solvent, and crystallization process used in sample preparation. Therefore, it has been difficult to detect double-stranded oligonucleotides such as siRNA using these mass spectrometry methods.
[0004] To address this issue, Non-Patent Document 1 describes the detection of siRNA by subjecting an analytical sample prepared using a neutral matrix, rather than an acidic matrix that readily affects hydrogen bonding, to MALDI mass spectrometry. Specifically, an analytical sample is prepared using 6-aza-2-thiothymine (ATT) as the matrix, ammonium citrate as the matrix additive, and water as the solvent, and siRNA is analyzed by MALDI-TOFMS, which combines a MALDI ion source with a time-of-flight mass spectrometer (TOFMS).
[0005] Ute Bahr, and 2 others, "Detection and Relative Quantification of siRNA Double Strands by MALDI Mass Spectrometry", Analytical Chemistry, 2008, Vol. 80, No. 16, pp. 6280-6285
[0006] In recent years, attempts have been made to use MALDI-ITMS, which combines a MALDI ion source with an ion trap mass spectrometer (ITMS), to analyze single-stranded oligonucleotides. However, even under conditions that allow for the analysis of single-stranded oligonucleotides, it has not been possible to analyze double-stranded oligonucleotides using MALDI-ITMS.
[0007] The problem to be solved by the present invention is to provide a novel method for analyzing double-stranded oligonucleotides using a MALDI ion trap mass spectrometer.
[0008] The present invention has been made to solve the above-mentioned problems by providing an ion trap mass spectrometer equipped with an ion source employing matrix-assisted laser desorption / ionization, an ion trapping section for trapping and ejecting ions generated in the ion source, and a detection section for detecting the ions ejected from the ion trapping section, thereby analyzing double-stranded oligonucleotides contained in the sample by introducing a sample into the ion source, irradiating the sample with a laser, trapping ions generated in the ion source in the ion trapping section, and then ejecting and detecting the ions trapped in the ion trapping section. The method is characterized in that a delay time, which is the time between irradiating the sample with a laser in the ion source and applying a trapping voltage to the ion trapping section to trap ions, is set longer than a value preset for the ion trap mass spectrometer as a delay time for trapping ions having a mass-to-charge ratio similar to that corresponding to the molecular weight of the double-stranded oligonucleotide.
[0009] According to the present invention, double-stranded oligonucleotides can be analyzed using a MALDI ion trap mass spectrometer.
[0010] 1 is a schematic diagram showing an example of a mass spectrometer (MALDI-ITMS) used in a method for analyzing double-stranded oligonucleotides according to one embodiment of the present invention. A figure showing the mass spectrum of butrisilane under various set conditions in Example 1 (Experimental Example 1-1). A figure showing the mass spectrum of butrisilane under different various set conditions in Example 1 (Experimental Example 1-1). A figure showing the mass spectrum of butrisilane in Example 1 (Experimental Example 1-2). A figure showing the mass spectrum of butrisilane in Example 1 (Experimental Example 1-3). A figure showing the mass spectrum of butrisilane in Example 2 (Experimental Example 2-1). A figure showing the mass spectrum of butrisilane in Example 2 (Experimental Example 2-2). A figure showing the mass spectrum of butrisilane in Example 2 (Experimental Example 2-3). A mass spectrum of patisiran under various set conditions in Example 3. A mass spectrum of patisiran under different various set conditions in Example 3. A mass spectrum of patisiran under further different various set conditions in Example 3.
[0011] Hereinafter, one embodiment of the method for analyzing double-stranded oligonucleotides according to the present invention will be described.
[0012] <Mass Spectrometer> A schematic diagram of the mass spectrometer used in this embodiment is shown in Figure 1. This mass spectrometer is a MALDI-ITMS that combines a MALDI ion source and an ion trap mass spectrometer, and includes an ion source 1 that ionizes a sample containing an analyte, an ion trap 2 that temporarily traps ions of a predetermined mass-to-charge ratio (m / z) from among the ions generated by the ion source 1 using the action of a radio frequency electric field and separates the trapped ions according to their mass-to-charge ratio, and a detector 3 that detects the separated ions.
[0013] (Ion Source) The ion source 1 is an ion source that utilizes the MALDI method, and includes a laser irradiation unit 11 that irradiates a sample with laser light, and a sample stage 12 on which a sample plate S on which a sample is placed is placed.
[0014] (Ion Trap) The ion trap 2 is a quadrupole ion trap including a circular ring electrode 21 and a pair of end cap electrodes 22, 23 arranged opposite each other across the ring electrode 21. An ion entrance aperture 22a is formed in the entrance end cap electrode 22, and an ion exit aperture 23a is formed in the exit end cap electrode 23.
[0015] A predetermined radio-frequency voltage is applied to the ring electrode 21 and the endcap electrodes 22, 23 of the ion trap 2. The applied radio-frequency voltage creates a radio-frequency electric field in the ion trap 2, which traps ions in the internal space enclosed by the ring electrode 21 and the endcap electrodes 22, 23 and ejects ions from the internal space through the ion exit hole 23a. The ITMS in this embodiment is a mass spectrometer that utilizes the mass separation function of the ion trap 2 itself to eject ions trapped in the ion trap 2 in ascending order of mass-to-charge ratio, and then detects the ions with a detector 3 located outside the ion trap 2. Alternatively, the ITMS may be a mass spectrometer that separates ions simultaneously ejected from the ion trap 2 according to their mass-to-charge ratios using a mass separator, such as a time-of-flight mass separator, located outside the ion trap 2, and then detects the ions with a detector 3 located outside the ion trap 2.
[0016] The radio frequency voltage applied to the ring electrode 21 and the end cap electrodes 22, 23 may be a sine wave voltage or a square wave voltage. An ion trap mass spectrometer that utilizes the electric field formed by the square wave voltage is called a digital ion trap mass spectrometer (DITMS).
[0017] When the radio frequency voltage is a sinusoidal voltage, it is difficult to change the frequency because a resonator is required for the voltage generator that generates the sinusoidal voltage, so the mass-to-charge ratio range of ions trapped in the ion trap 2 is controlled by changing the amplitude of the voltage.
[0018] On the other hand, when the radio frequency voltage is a square wave voltage, it can be generated by rapidly switching between two different voltages without using a resonator in the voltage generator. Therefore, in DITMS, the mass-to-charge ratio range of ions trapped in the ion trap 2 can be controlled by changing the frequency while keeping the voltage amplitude constant. Specifically, the low mass cutoff (LMCO) is set by adjusting the frequency of the radio frequency voltage; the higher the frequency, the smaller the LMCO. Because there is an upper limit to the amount of ions that can be trapped in the ion trap 2, the mass-to-charge ratio range of ions trapped in the ion trap 2 (i.e., the mass-to-charge ratio range measured by DITMS) is set to the low mass-to-charge ratio side by increasing the frequency and setting a small LMCO, and vice versa.
[0019] (Detector) The detector 3 includes a conversion dynode 31 that converts ions into electrons and a secondary electron multiplier 32 that multiplies the electrons arriving from the conversion dynode 31. A high voltage of the opposite polarity to the ions to be detected, i.e., a negative voltage for positive ions and a positive voltage for negative ions, is applied to the conversion dynode 31. The secondary electron multiplier 32 has a multi-stage or continuous dynode configuration, and by applying a voltage to the secondary electron multiplier 32, the secondary electrons emitted when electrons arriving from the conversion dynode 31 are incident on the secondary electron multiplier 32 are repeatedly multiplied. The multiplied secondary electrons are then converted into a current signal and detected. The voltages applied to the conversion dynode 31 and the secondary electron multiplier 32 are preset to device-specific specified values according to the mass-to-charge ratio range of the ions to be trapped in the ion trap 2.
[0020] As a result of extensive investigations, the present inventors have found that double-stranded oligonucleotides can be detected by mass spectrometry in a MALDI-ITMS by appropriately setting the time (hereinafter referred to as the delay time) between irradiating a sample with laser light from the ion source 1 and applying a radio-frequency voltage to the ring electrode 21 of the ion trap 2. Specifically, the delay time is set to a time longer than the value preset for the MALDI-ITMS as the delay time for trapping ions having a mass-to-charge ratio similar to that corresponding to the molecular weight of the double-stranded oligonucleotide, which is the substance to be analyzed.
[0021] Generally, when substances such as peptides and proteins are analyzed by MALDI mass spectrometry, the main component is [M+H] + or [MH] - It is known that molecular weight-related ions such as [M+H] (where M is a molecule and H is a hydrogen atom) can be detected. For example, the molecular weight of a substance with a molecular weight of about 15,000 is [M+H] + or [MH] - When it is desired to detect [M+H] of a substance with a molecular weight of about 15,000, the delay time is usually set to about 25 μs. However, such a delay time did not allow detection of double-stranded oligonucleotides with a similar molecular weight. On the other hand, when the delay time was set to, for example, 80 μs, which is longer than the above value, it was confirmed that a peak derived from double-stranded oligonucleotides was detected. Generally, as the delay time becomes longer, ions with a higher mass-to-charge ratio are preferentially trapped in the ion trap 2. However, the above-mentioned delay time value (80 μs) does not allow detection of [M+H] of a substance with a molecular weight of about 15,000. + or [MH] - This is a value that preferentially traps ions with a mass-to-charge ratio much larger than 80 μs. In other words, the delay time of 80 μs is outside the range expected from the commonly known relationship between the mass-to-charge ratio of the detected ions and the delay time.
[0022] The delay time can be set to an appropriate value depending on the molecular weight of the double-stranded oligonucleotide. For example, setting the delay time to a value in the range of 40 to 80 μs enables sensitive detection of double-stranded oligonucleotides with a molecular weight of 10,000 or greater. From the viewpoint of improving sensitivity, a setting of 60 to 80 μs within the above range is more preferable. Considering that a typical delay time for preferentially trapping ions with a mass-to-charge ratio of approximately 20,000 to 70,000 in the ion trap 2 is approximately 50 μs, it is understood that the above-mentioned delay time range is unexpected. Note that, in this specification, a numerical range from a lower limit to an upper limit is indicated using the symbol "to" as "(lower limit) to (upper limit)," but the numerical range indicated in this manner includes both the lower limit and the upper limit.
[0023] In addition to setting the delay time, at least one of the voltages applied to the conversion dynode 31 and the secondary electron multiplier 32 of the detector 3 may be increased above the device-specific default value to increase the signal intensity of ions detected by the detector 3. This allows for more sensitive detection of double-stranded oligonucleotides. Hereinafter, the voltage applied to the conversion dynode 31 is referred to as the dynode voltage, and the voltage applied to the secondary electron multiplier 32 is referred to as the detector voltage. The dynode voltage should be set approximately 5 to 30% higher than the device-specific default value. Furthermore, the detector voltage should be set approximately 5 to 50% higher than the device-specific default value. For example, if the default value is 7000 V, the dynode voltage should be set to approximately 8000 V, and if the default value is 1300 V, the detector voltage should be set to approximately 1600 to 2000 V.
[0024] <Sample for Analysis> The sample for analysis is prepared by mixing a sample solution containing a double-stranded oligonucleotide with a matrix solution containing a matrix, and drying the mixture on a sample plate S of a mass spectrometer. At this time, a mixture of the sample solution and the matrix solution may be prepared in advance, and the mixture may be dropped onto the sample plate S and dried, or the sample solution and the matrix solution may be dropped separately onto the sample plate S, and then mixed and dried on the sample plate S.
[0025] (Double-Stranded Oligonucleotide) The double-stranded oligonucleotide serving as the analyte of this embodiment may be DNA or RNA. The length of the double-stranded oligonucleotide is not particularly limited, and may be, for example, approximately several tens of base pairs. The double-stranded oligonucleotide may be a chemically synthesized artificial nucleic acid such as a nucleic acid drug, or may be a natural product obtained from an organism or a processed product thereof. The molecular weight of the double-stranded oligonucleotide serving as the analyte may be known or unknown. If the structure of the double-stranded oligonucleotide is known, the molecular weight can be calculated from its chemical formula. Alternatively, the molecular weight may be measured in advance by a method other than mass spectrometry, such as electrophoresis. For example, if the double-stranded oligonucleotide is siRNA, the molecular weight of the double-stranded oligonucleotide is approximately 1,000 to 30,000.
[0026] (Matrix) The matrix may be selected from a variety of materials depending on the type of double-stranded oligonucleotide, including, for example, 3-hydroxypicolinic acid (3-HPA), 2,4-dihydroxyacetophenone (2,4-DHAP), 2,5-dihydroxybenzoic acid (DHB), 2',4',6'-trihydroxyacetophenone monohydrate (THAP), 6-aza-2-thiothymine (ATT), 3-aminopyrazine-2-carboxylic acid (APCA), anthranilic acid (AA), and nicotinic acid (NA). As the matrix, 3-HPA, DHAP, and THAP are preferred, with 3-HPA being particularly preferred, since double-stranded nucleotides can be detected with high sensitivity.
[0027] The matrix solution may be a mixed matrix solution containing two or more matrices, preferably containing at least 3-HPA, more preferably 3-HPA and THAP or 3-HPA and 2,4-DHAP.
[0028] The concentration of the matrix in the matrix solution is not particularly limited, but the [M+H] of the double-stranded oligonucleotide + or [MH] - A concentration of 30 to 50 mg / mL is preferred because it allows for sensitive detection.
[0029] (Matrix Additive) The matrix solution may further contain a matrix additive. As the matrix additive, diammonium citrate dibasic (ACD) can be used. There are several types of ammonium salts of citric acid depending on the number of ammonium ions bonded to the citrate ion, but the salt preferably used in this embodiment is one in which two ammonium ions are bonded to one citrate ion.
[0030] The concentration of the matrix additive in the matrix solution is not particularly limited, but may be adjusted to the [M+H] of the double-stranded oligonucleotide. + or [MH] - In terms of enabling detection with high sensitivity, the concentration is preferably 70 to 200 mM, and more preferably 100 to 200 mM.
[0031] (Solvent) Since double-stranded oligonucleotides are water-soluble and their double-stranded structure is stabilized by hydrogen bonds in the liquid phase, water is preferably used as the solvent for the sample solution. The solvent for the matrix solution preferably contains water, and may contain a polar solvent such as acetonitrile.
[0032] The method for analyzing double-stranded oligonucleotides according to the present invention will be explained below with reference to examples, but these are merely examples and the present invention is not limited thereto.
[0033] (Experimental Example 1-1) <1. Preparation of sample solution> As a sample solution, vutrisiran (siRNA (double-stranded RNA consisting of a sense strand and an antisense strand, MW 16344.55 Da, synthetic nucleic acid for research use, manufactured by MedchemExpress) (sense strand: 5'-Ums-Gms-Gm-Gm-Am-Um-Uf-Um-Cf-Af-Uf-Gm-Um-Am-Am-Cm-Cm-Am-Am-Gm-Am-R1-3' (Af = 2'-fluoroadenosine, Am = 2'-O-methyladenosine, Cf = 2'-fluorocytidine, Cm = 2'-O-methylcytidine, Gm = 2'-O-methylguanosine, Uf = 2'-fluorouridine, Um = 2'-O-methyluridine, R1 = 3-branched N-acetylgalactosamine (GalNAc), s-(hyphen) = phosphorothioate bond), SEQ ID NO: 1, MW 8788.55 Da) (antisense strand: 3'-Cms-Ums-Am-Cm-Cm-Cm-Um-Af-Am-Af-Gm-Um-Am-Cm-Af-Um-Um-Gf-Gm-Um-Ums-Cfs-Um-5' (Af = 2'-fluoroadenosine, Am = 2'-O-methyladenosine, Cf = 2'-fluorocytidine, Cm = 2'-O-methylcytidine, Gf = 2'-fluoroguanosine, Gm = 2'-O-methylguanosine, Um = 2'-O-methyluridine, s-(hyphen) = phosphorothioate bond), SEQ ID NO: 2, MW 7556.00 Da) An aqueous solution of pmol / μL was prepared.
[0034] 2. Preparation of matrix solution: Diammonium hydrogen citrate (ACD) was dissolved in 50% acetonitrile water to a concentration of 200 mM as a matrix additive to prepare an ACD solution. 3-Hydroxypicolinic acid (3-HPA) was dissolved in the ACD solution to a concentration of 40 mg / mL as a matrix to prepare a matrix solution.
[0035] <3. Preparation of analytical sample> The sample solution prepared in 1. and the matrix solution prepared in 2. were mixed at a 1:1 (v / v) ratio, and 1 μL of the resulting mixture was dropped onto a sample plate (SUS plate) and dried.
[0036] <4. Mass Analysis> Mass analysis was performed using a MALDI digital ion trap mass spectrometer (MALDI-DITMS, Shimadzu Corporation, product name: MALDImini-1). The sample plate from 3 was inserted into the MALDI-DITMS, and measurements were performed using the raster function in positive mode. Measurement conditions included mode 3 (m / z 2000-18000), which is a mass-to-charge ratio range tailored to the molecular weight of the siRNA contained in the analysis sample. Measurements were performed using the optimal laser power (threshold value) and the instrument-specific settings (detector voltage (DV1): 1300 (V), dynode voltage (DV2): 7000 (V), delay time (RF delay: RF): 25 (μs)) preset for the measurement mode. Measurements were also performed by appropriately adjusting the detector voltage (DV1), dynode voltage (DV2), and delay time (RF).
[0037] <Results> Figure 2 shows the mass spectrum of vutrisiran when 3-HPA was used as the matrix. When measured under the instrument-specific settings (DV1: 1300, DV2: 7000, RF: 25), two peaks, one from the sense strand and one from the antisense strand, were observed, both of which were [M+H]. + However, the peak derived from the double strand was not detected (Fig. 2(a)). On the other hand, when the detector voltage (DV1) and dynode voltage (DV2) were increased to amplify the signal intensity (DV1: 1800, DV2: 8000, RF: 25), the peak derived from the double strand was detected as [M+H]. + However, the sensitivity was low (Fig. 2(b)). When the delay time (RF) was increased (DV1: 1800, DV2: 8000, RF: 80), the peak derived from the double strand was detected with high sensitivity (Fig. 2(c)).
[0038] Figure 3 shows the mass spectra of vutrisiran measured at various RF delays (RF) using 3-HPA as the matrix, with a detector voltage of DV1: 1800 and a dynode voltage of DV2: 8000. The mass spectra are shown at RFs of 25, 40, 60, 80, and 100, respectively, from bottom to top. The right side of each column shows a magnified view of the m / z region of the double-stranded peak. The arrows in the figure indicate the detection of the double-stranded peak, and the numbers in the magnified view indicate the peak intensity (mV). Figure 3 shows that double-stranded peaks were detected at all RF delays, but RFs of 25 and 100 exhibited significant noise and low peak intensity (Figures 3(a) and (e)). On the other hand, noise was low at RF: 40-80 (Fig. 3(b)-(d)), and peaks derived from double strands were detected with high sensitivity especially at RF: 60 and 80 (Fig. 3(c) and (d)).
[0039] (Experimental Example 1-2) Mass spectrometry was carried out in the same manner as in Experimental Example 1-1, except that the method for preparing the matrix solution was different.
[0040] 2. Preparation of Matrix Solutions: ACD was dissolved in 50% aqueous acetonitrile to a concentration of 200 mM as a matrix additive to prepare an ACD solution. 3-HPA, 2,4-dihydroxyacetophenone (DHAP), or 2',4',6'-trihydroxyacetophenone monohydrate (THAP) was dissolved in the ACD solution to a concentration of 40 mg / mL as a matrix to prepare three matrix solutions (3-HPA solution, DHAP solution, and THAP solution). 3-HPA solution and THAP solution were mixed at 1:1 (v / v) and 1:3 (v / v) ratios to prepare two mixed matrix solutions (3-HPA / THAP (1:1) solution and 3-HPA / THAP (1:3) solution).
[0041] <Results> Figure 4 shows the mass spectra of vutrisiran when using various matrices (DHAP, THAP, 3-HPA / THAP (1:1), and 3-HPA / THAP (1:3)). The mass spectrum on the left was measured using the instrument's specific settings (DV1: 1300, DV2: 7000, RF: 25). The mass spectrum on the right was measured using the conditions (DV1: 1800, DV2: 8000, RF: 80) under which double-stranded peaks were detected with high sensitivity in Experiment 1-1 (hereinafter, these settings will be referred to as double-stranded detection settings). The arrows in the figure indicate the detection status of double-stranded peaks, and ND indicates no detection. Where double-stranded peaks were detected, an enlarged view of the m / z region around the peak is also shown. As with the use of 3-HPA as the matrix, double-stranded peaks were detected with either matrix when the detector voltage (DV1), dynode voltage (DV2), and delay time (RF) were increased beyond the instrument-specific settings. Figures 2 to 4 confirm that 3-HPA provided the most sensitive detection of siRNA.
[0042] Experimental Example 1-3 Mass spectrometry was carried out in the same manner as in Experimental Example 1-1 of Example 1, except that the method for preparing the matrix solution was different.
[0043] 2. Preparation of matrix solutions: ACD was dissolved in 50% acetonitrile aqueous solution to prepare five ACD solutions (70, 100, 200, 300, 400 mM) as a matrix additive. 3-HPA was dissolved in each of these five ACD solutions to prepare five matrix solutions (40 mg / mL).
[0044] Results: Figure 5 shows the mass spectra of vutrisiran at various ACD concentrations in the matrix solution using 3-HPA as the matrix. From the bottom, the mass spectra are for 70, 100, 200, 300, and 400 mM ACD. The left side of each spectrum was measured using the instrument-specific settings, while the right side was measured using the double-strand detection settings. The right side of each spectrum also shows a magnified view of the m / z region of the double-strand peak. For peaks detected as double-stranded, the peak intensity (mV) is shown. Figure 5 shows that double-stranded peaks were detected using the double-strand detection settings at ACD concentrations between 70 and 200 mM. Furthermore, the peak intensity of double-stranded peaks was higher with a 200 mM ACD matrix solution than with a 70 mM ACD matrix solution. While detailed data are not presented here, 70 mM ACD was the optimal concentration for the analysis of single-stranded oligonucleotides. The sodium ions (Na ) in the sample were more likely to be present in double-stranded oligonucleotides than in single-stranded oligonucleotides. + ) and this Na + It has been reported that a high concentration of Na inhibits the ionization of the sample. In this experiment, the peak intensity of the double-stranded peak was higher when the ACD concentration was 200 mM than when it was 70 mM. + One possible reason is that the higher the concentration of ACD, which is thought to have the role of capturing ions, the less likely ionization is inhibited.
[0045] These results demonstrate that for double-stranded oligonucleotides, increasing the detector voltage (DV1), dynode voltage (DV2), and delay time (RF) beyond the instrument-specific settings is effective. Such settings for double-stranded oligonucleotide detection enabled detection of double-stranded peaks with multiple matrices. 3-HPA was the most suitable matrix. Furthermore, we confirmed that double-stranded peaks were detected with greater sensitivity at concentrations of the matrix additive, diammonium hydrogen citrate, higher than the optimal concentration for single-stranded oligonucleotide analysis.
[0046] (Experimental Example 2-1) Mass spectrometry was carried out in the same manner as in Experimental Example 1-1 of Example 1, except that the method for preparing the matrix solution was different.
[0047] 2. Preparation of matrix solutions: ACD was dissolved in 50% acetonitrile aqueous solution to a concentration of 200 mM as a matrix additive to prepare an ACD solution. 3-HPA or 6-aza-2-thiothymine (ATT) was dissolved in the ACD solution to a concentration of 40 mg / mL as a matrix to prepare two types of matrix solutions (3-HPA solution, ATT solution).
[0048] <Results> Figure 6 shows the mass spectra of vutrisiran when 3-HPA or ATT was used as the matrix. The upper panel shows the mass spectrum when 3-HPA was used, and the lower panel shows the mass spectrum when ATT was used. The left panel shows the mass spectrum measured using instrument-specific settings, while the right panel shows the mass spectrum measured using double-strand detection settings. The R in the figure indicates the resolution of double-strand peaks. Non-Patent Document 1 describes that double-strand peaks are more easily detected when using the neutral matrix ATT compared to the acidic matrix 3-HPA. However, in this experimental example, although double-strand peaks were detected under the double-strand detection settings in both matrices, the mass spectrum measured using ATT had more noise and lower peak resolution than the mass spectrum measured using 3-HPA, resulting in poor overall mass spectral quality.
[0049] (Experimental Example 2-2) Mass spectrometry was carried out in the same manner as in Experimental Example 1-1 of Example 1, except that the method for preparing the matrix solution was different.
[0050] <2. Preparation of matrix solutions> Two types of ACD solutions were prepared by dissolving ACD as a matrix additive in 50% acetonitrile aqueous solution or water to a concentration of 200 mM. 3-HPA was dissolved in each of these two ACD solutions as a matrix to a concentration of 40 mg / mL to prepare two types of matrix solutions (3-HPA solution, 3-HPA aqueous solution).
[0051] <Results> Figure 7 shows the mass spectra of vutrisiran when 3-HPA was used as the matrix and either 50% acetonitrile or water was used as the matrix solution solvent. The upper panel shows the mass spectrum when 50% acetonitrile was used, and the lower panel shows the mass spectrum when water was used. The left panel shows the mass spectrum measured using instrument-specific settings, while the right panel shows the mass spectrum measured using double-stranded oligonucleotide detection settings. According to Non-Patent Document 1, acetonitrile enhances matrix solubility but inhibits detection of double-stranded oligonucleotides. However, in this experimental example, it was confirmed that double-stranded peaks were detected with high sensitivity under double-stranded oligonucleotide detection settings, regardless of whether 50% acetonitrile or water was used as the solvent.
[0052] Experimental Example 2-3 Mass spectrometry was carried out in the same manner as in Experimental Example 1-1 of Example 1, except that the method for preparing the matrix solution was different.
[0053] 2. Preparation of Matrix Solutions An ACD solution was prepared by dissolving ACD as a matrix additive in 50% acetonitrile aqueous solution to a concentration of 200 mM. 3-HPA as a matrix was dissolved in the ACD solution to a concentration of 40 mg / mL to prepare a matrix solution (3-HPA solution). Two types of ACD aqueous solutions were prepared by dissolving ACD in water to a concentration of 100 mM or 200 mM. 3-HPA was dissolved in each of these two types of ACD aqueous solutions to a concentration of 40 mg / mL to prepare two types of matrix solutions (3-HPA aqueous solutions). Another ACD solution was prepared by dissolving ACD as a matrix additive in 50% acetonitrile aqueous solution to a concentration of 200 mM. ATT as a matrix was dissolved in the ACD solution to a concentration of 40 mg / mL to prepare a matrix solution (ATT solution). ACD was dissolved in water to a concentration of 100 mM to prepare an ACD aqueous solution, and ATT was dissolved in the ACD aqueous solution to a concentration of 6 mg / mL to prepare a matrix solution (ATT aqueous solution).
[0054] <Results> Figure 8 shows the mass spectra of vutrisiran obtained using various matrix solutions containing 3-HPA or ATT. The left side shows the results measured using the instrument-specific settings, while the right side shows the results measured using the double-strand detection settings. The right side of the mass spectrum also shows a magnified view of the m / z region of the double-stranded peak. The numbers in the magnified view indicate the peak intensity (mV) and resolution (R) of the peak. When ATT was used as the matrix (Figures 8(d) and (e)), double-stranded peaks were detected, but the noise was high and resolution was low. In Figures 8(d) and (e), peaks derived from the sense and antisense dimers (in the magnified views, the peak derived from the sense dimer is labeled 2ss and the peak derived from the antisense dimer is labeled 2as) and multiple peaks derived from base-desorbed ions were detected. The matrix solution conditions in Figure 8(e) are the same as those used to detect siRNA by MALDI-TOFMS in Non-Patent Document 1. In contrast, when 3-HPA was used (Figures 8(a) to (c), especially Figures 8(a) and (c)), double-stranded peaks were detected with high sensitivity and high resolution. Furthermore, in Figures 8(a) to (c), no peaks derived from dimers were detected, and there were few peaks derived from base desorbed ions, resulting in a relatively simple mass spectrum.
[0055] From the above, it was confirmed that when measurements were performed using MALDI-DITMS under the conditions set for double-strand detection, better mass spectra could be obtained using the acidic matrix 3-HPA than using the neutral matrix ATT recommended in Non-Patent Document 1.
[0056] <1. Preparation of sample solution> As a sample solution, 20 ml of patisiran (siRNA (double-stranded RNA consisting of a sense strand and an antisense strand), MW 13,424 Da, synthetic nucleic acid for research use manufactured by Gene Design Inc.) (sense strand: 5'-G-Um-AA-Cm-Cm-AAGAG-Um-A-Um-Um-Cm-Cm-A-Um-dT-dT-3' (dT = thymidine deoxyribonucleotide, Cm = 2'-O-methylcytidine, Um = 2'-O-methyluridine), SEQ ID NO: 3, MW 6,764 Da) (antisense strand: 3'-dT-dT-CA-Um-UGGUUCUCA-Um-AAGGUA-5' (dT = thymidine deoxyribonucleotide, Cm = 2'-O-methylcytidine, Um = 2'-O-methyluridine), SEQ ID NO: 4, MW 6,660 Da) was prepared. An aqueous solution of pmol / μL was prepared.
[0057] 2. Preparation of matrix solutions Two types of ACD solutions were prepared by dissolving ACD as a matrix additive in 50% acetonitrile aqueous solution to a concentration of 70 mM or 200 mM. 3-HPA as a matrix was dissolved in each of these two ACD solutions to a concentration of 40 mg / mL, thereby preparing two types of matrix solutions.
[0058] <3. Preparation of analytical sample> The sample solution prepared in 1. and the matrix solution prepared in 2. were mixed at a 1:1 (v / v) ratio, and 1 μL of the resulting mixture was dropped onto a sample plate (SUS plate) and dried.
[0059] <4. Mass Analysis> Mass analysis was performed using a MALDI digital ion trap mass spectrometer (MALDI-DITMS, Shimadzu Corporation, product name: MALDImini-1). The sample plate from step 3 was inserted into the MALDI-DITMS, and measurements were performed using the raster function in positive mode. Measurement conditions included mode 3 (m / z 2000-18000), which corresponds to the mass-to-charge ratio range of the siRNA contained in the analytical sample. Measurements were performed using the specified instrument settings of detector voltage (DV1): 1300 (V), dynode voltage (DV2): 7000 (V), and delay time (RF): 25 (μs), with the optimal laser power (threshold value). Measurements were also performed by adjusting the detector voltage (DV1), dynode voltage (DV2), and delay time (RF) as appropriate.
[0060] <Results> Figure 9 shows the mass spectra of patisiran under various settings when 3-HPA was used as the matrix and the ACD concentration in the matrix solution was varied. The upper panel shows the mass spectrum at 70 mM ACD, and the lower panel shows the mass spectrum at 200 mM ACD. In both the 70 mM and 200 mM ACD cases, when measured under the instrument-specific settings (DV1: 1300, DV2: 7000, RF: 25), two peaks, mainly derived from the sense strand and the antisense strand, were observed, both of which were [M+H]. + However, no peaks derived from the double strand were detected (Figure 9(a)). On the other hand, when measurements were performed under conditions with increased delay times (RF) (DV1: 1300, DV2: 7000, RF: 80), the peaks derived from the double strand were detected as [M+H] at both 70 mM and 200 mM ACD. +The double-stranded peaks were detected as α-amino acids. However, the signal-to-noise ratio (S / N) was low (Figure 9(b)). Furthermore, when the detector voltage (DV1) and dynode voltage (DV2) were increased (DV1: 1800, DV2: 8000, RF: 80), the double-stranded peaks were detected with high sensitivity at both 70 and 200 mM ACD (Figure 9(c)). In Figure 9(c), the sensitivity was higher at 200 mM ACD than at 70 mM. These results confirm that double-stranded peaks can be detected with high sensitivity by adjusting not only the delay time but also the detector voltage and dynode voltage to values higher than those specified by the instrument.
[0061] Figure 10 shows the mass spectra of patisiran measured using 3-HPA as the matrix. The detector voltage (DV1) and dynode voltage (DV2) were kept constant from the instrument's inherent settings (DV1: 1300, DV2: 7000), but the delay time (RF) was varied. From the bottom, the RFs were 25, 40, 60, and 80, respectively. The left side shows the mass spectrum at an ACD of 70 mM, and the right side shows the mass spectrum at an ACD of 200 mM. Figure 10 demonstrates that while increasing the delay time without changing the detector voltage or dynode voltage results in the detection of double-stranded peaks, the S / N ratio decreases as the delay time increases.
[0062] Meanwhile, Figure 11 shows the mass spectra of patisiran measured under conditions where the detector voltage (DV1) and dynode voltage (DV2) were increased from the instrument-specific settings (DV1: 1800, DV2: 8000) and the delay time (RF) was varied. From the bottom, the RF values are 25, 40, 60, and 80, respectively. The left side shows the mass spectrum at 70 mM ACD, and the right side shows the mass spectrum at 200 mM ACD. Figure 11 shows that increasing the detector voltage and dynode voltage did not significantly decrease the S / N ratio, even with increasing the delay time. As a result, double-stranded peaks were detected most sensitively at RF: 80, and at this RF value, ACD 200 mM was more sensitive than ACD 70 mM. Furthermore, it was confirmed that double-stranded peaks could be detected more sensitively by adjusting not only the delay time but also the detector voltage and dynode voltage to values greater than those specified by the instrument.
[0063] Aspects It will be apparent to those skilled in the art that the exemplary embodiments described above are examples of the following aspects.
[0064] (Item 1) A method for analyzing double-stranded oligonucleotides according to one aspect of the present invention uses an ion trap mass spectrometer equipped with an ion source employing matrix-assisted laser desorption ionization, an ion trapping section for trapping and ejecting ions generated in the ion source, and a detection section for detecting ions ejected from the ion trapping section, to analyze double-stranded oligonucleotides contained in the sample by introducing a sample into the ion source, irradiating the sample with a laser, trapping ions generated in the ion source in the ion trapping section, and then ejecting and detecting the ions trapped in the ion trapping section, wherein a delay time, which is the time between irradiating the sample with a laser in the ion source and applying a trapping voltage to the ion trapping section for trapping ions, is set longer than a value preset for the ion trap mass spectrometer as a delay time for trapping ions having a mass-to-charge ratio similar to that corresponding to the molecular weight of the double-stranded oligonucleotide.
[0065] Generally, in an analysis using an ion trap mass spectrometer, the relationship between the mass-to-charge ratio of the ions to be detected and the delay time is known from experience. The "predetermined value" is the [M+H] value corresponding to the molecular weight of the double-stranded oligonucleotide based on the empirically known relationship between the mass-to-charge ratio of the ions to be detected and the delay time. + or [MH] - This refers to a value that is preset in a mass spectrometer as a delay time for trapping ions having a mass-to-charge ratio similar to that of the target ion.
[0066] The molecular weight of the double-stranded oligonucleotide, which is the analyte, may be unknown or known.When the molecular weight of the double-stranded oligonucleotide, which is the analyte, is known, mass spectrometry is performed in a mass range containing a mass-to-charge ratio corresponding to the molecular weight under conditions in which the delay time is set longer than a preset value, thereby confirming the presence or absence of a peak that provides molecular weight information.On the other hand, when the molecular weight of the double-stranded oligonucleotide, which is the analyte, is unknown, mass spectrometry is performed in each of several candidate mass ranges containing a mass-to-charge ratio corresponding to the expected molecular weight of the double-stranded oligonucleotide under conditions in which the delay time is set longer than a preset value, thereby confirming the presence or absence of a peak that provides molecular weight information.
[0067] According to the method for analyzing a double-stranded oligonucleotide according to the first aspect, the double-stranded oligonucleotide can be analyzed using a MALDI ion trap mass spectrometer.
[0068] (Item 2) In the method for analyzing double-stranded oligonucleotides according to item 1, the detection unit may comprise a conversion dynode and a secondary electron multiplier, and at least one of the voltage applied to the conversion dynode and the voltage applied to the secondary electron multiplier may be set higher than a preset device-specific setting value according to the mass-to-charge ratio range of ions trapped in the ion trapping unit of the ion trap mass spectrometer.
[0069] According to the method for analyzing double-stranded oligonucleotides according to the second aspect, double-stranded oligonucleotides can be analyzed with higher sensitivity.
[0070] (Item 3) In the method for analyzing a double-stranded oligonucleotide according to item 1 or 2, the delay time may be 60 to 80 μsec.
[0071] According to the method for analyzing double-stranded oligonucleotides according to the third aspect, double-stranded oligonucleotides can be analyzed with high sensitivity.
[0072] (4) In the method for analyzing a double-stranded oligonucleotide according to any one of the first to third aspects, the ion trap mass spectrometer may be a digital ion trap mass spectrometer.
[0073] According to the method for analyzing double-stranded oligonucleotides according to the fourth aspect, double-stranded oligonucleotides can be analyzed with higher sensitivity.
[0074] (Item 5) In the method for analyzing a double-stranded oligonucleotide according to any one of Items 1 to 4, an analytical sample containing the sample, a matrix, and diammonium hydrogen citrate as a matrix additive may be prepared, and the analytical sample may be subjected to mass analysis using the ion trap mass spectrometer.
[0075] According to the method for analyzing double-stranded oligonucleotides relating to item 5, an analytical sample suitable for mass spectrometry using a MALDI ion trap mass spectrometer can be prepared, and double-stranded oligonucleotides can be analyzed.
[0076] (Item 6) In the method for analyzing a double-stranded oligonucleotide according to Item 5, when a matrix solution containing the matrix, the diammonium hydrogen citrate, and a solvent is prepared, the concentration of the diammonium hydrogen citrate in the matrix solution may be 100 to 200 mM.
[0077] (Item 7) In the method for analyzing a double-stranded oligonucleotide according to either item 5 or 6, the matrix may contain at least 3-hydroxypicolinic acid, or may be 2',4',6'-trihydroxyacetophenone monohydrate or 2,4-dihydroxyacetophenone.
[0078] (Item 8) In the method for analyzing a double-stranded oligonucleotide according to any one of Items 5 to 7, the solvent may be water or a mixed solvent of water and acetonitrile.
[0079] According to the method for analyzing a double-stranded oligonucleotide according to any one of items 6 to 8, the double-stranded oligonucleotide can be analyzed with higher sensitivity.
[0080] (Item 9) In the method for analyzing a double-stranded oligonucleotide according to any one of Items 1 to 8, the double-stranded oligonucleotide may be siRNA.
[0081] REFERENCE SIGNS LIST 1 ion source 2 ion trap 3 detection unit 11 laser irradiation unit 12 sample stage 21 ring electrode 22, 23 end cap electrodes 31 conversion dynode 32 secondary electron multiplier
Claims
1. A method for analyzing double-stranded oligonucleotides contained in a sample by using an ion trap mass spectrometer equipped with an ion source using a matrix-assisted laser desorption / ionization method, an ion trapping section for trapping and ejecting ions generated in the ion source, and a detection section for detecting the ions ejected from the ion trapping section, by introducing a sample into the ion source, irradiating the sample with a laser, trapping ions generated in the ion source in the ion trapping section, and then ejecting and detecting the ions trapped in the ion trapping section, wherein a delay time, which is the time from irradiating the sample with a laser in the ion source to applying a trapping voltage to the ion trapping section for trapping ions, is set to be longer than a value preset for the ion trap mass spectrometer as a delay time for trapping ions having a mass-to-charge ratio similar to that corresponding to the molecular weight of the double-stranded oligonucleotide.
2. A method for analyzing double-stranded oligonucleotides as described in claim 1, wherein the detection unit comprises a conversion dynode and a secondary electron multiplier, and at least one of the voltage applied to the conversion dynode and the voltage applied to the secondary electron multiplier is set higher than a device-specific setting value that is preset in accordance with the mass-to-charge ratio range of ions captured in the ion trapping unit of the ion trap mass spectrometer.
3. The method for analyzing a double-stranded oligonucleotide according to claim 1, wherein the delay time is 60 to 80 μsec.
4. The method for analyzing a double-stranded oligonucleotide according to claim 1, wherein the ion trap mass spectrometer is a digital ion trap mass spectrometer.
5. A method for analyzing double-stranded oligonucleotides according to claim 1, comprising preparing an analytical sample containing the sample, a matrix, and diammonium hydrogen citrate as a matrix additive, and subjecting the analytical sample to mass analysis using the ion trap mass spectrometer.
6. The method for analyzing a double-stranded oligonucleotide according to claim 5, wherein when a matrix solution containing the matrix, the diammonium hydrogen citrate, and a solvent is prepared, the concentration of the diammonium hydrogen citrate in the matrix solution is 100 to 200 mM.
7. The method for analyzing a double-stranded oligonucleotide according to claim 5, wherein the matrix contains at least 3-hydroxypicolinic acid, or is 2',4',6'-trihydroxyacetophenone monohydrate or 2,4-dihydroxyacetophenone.
8. The method for analyzing a double-stranded oligonucleotide according to claim 5, wherein the solvent is water or a mixed solvent of water and acetonitrile.
9. The method for analyzing a double-stranded oligonucleotide according to claim 1, wherein the double-stranded oligonucleotide is an siRNA.
Citation Information
Patent Citations
Mass spectrometer and mass calibration method
JP2020202102A
Ion introduction method into ion trap, ion trap mass spectrometer, and ion trap mass spectrometry program
JP2022052108A
Cited By
Method for analyzing morpholine ring-containing oligonucleotide
WO2025216296A1
